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Cardiovascular disease is responsible for about one-third of
deaths in developed countries and contributes to substantial
health care costs [1]. Even in developing nations, cardiovas-
cular disease is on the rise, especially in urban areas [2].
Increased central adiposity is associated with a clustering
of risk factors for cardiovascular disease, including eleva-
tion in fasting triglycerides and glucose, increased resting
blood pressure, and decreased levels of fasting high density
lipoproteins. This clustering of risk factors is termed the
“metabolic syndrome” [3]. Increased visceral adipose tissue is
integral to development ofmetabolic syndrome and increases
risk of type 2 diabetes, cardiovascular disease complications,
cancer, sleep disorders, sexual dysfunction, andmortality [4–
7]. Exercise training can have a profound effect on reducing
visceral adiposity and therefore reduces metabolic syndrome
risk [8, 9].
As outlined in the review by T. Sakurai et al., adipose
tissue does not only serve as a storage site for energy but
is now recognized as having substantial endocrine func-
tion, releasing a number of “adipokines” and “cytokines.”
Adipokines include leptin and adiponectin and cytokines
include inflammatory (i.e., TNF-alpha, IL-6) and anti-
inflammatory (i.e., IL-10) cytokines. Adiponectin is consid-
ered to be anti-inflammatory and associated with improved
insulin sensitivity, whereas leptin affects the hypothalamus
to suppress appetite. Increased fat cell size is associated
with dysregulation of adipokines and cytokines so that
adiponectin release is decreased and inflammatory cytokine
release is increased [10, 11]. This increased inflammatory
state is association with increased insulin resistance. Exercise
training or increased physical activity, especially that which
is associated with reduced fat mass, corrects the dysfunction
in adipokine and cytokine expression so that expression of
adiponectin is increased in adipose tissue and production of
inflammatory cytokines is reduced [12, 13].
A number of articles in this issue investigate the effects of
exercise programs onmetabolic syndrome, insulin resistance,
and adipokine and cytokine dysfunction in understudied
populations, including children, breast cancer survivors, and
those who have had adipose tissue removed through liposuc-
tion. Y. Kim andH. Park review the effects of exercise training
programs for alleviating insulin resistance in children.This is
an important population to investigate as the proportion of
adolescents withmetabolic syndrome is estimated at between
6.5 and 7.8% [14] andmetabolic syndrome risk in adolescence
tracks into adulthood in longitudinal studies [15]. As outlined
by Y. Kim and H. Park, there is good evidence that exercise
training independent of weight loss is effective for reducing
insulin resistance in adults but limited evidence that aerobic
or resistance training is effective in children and adolescents.
Therefore, there is a need for larger randomized controlled
trials to determine optimal doses and modalities of exercise
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for prevention of metabolic syndrome and insulin resistance
in children.
G. A. Thomas et al. investigated the effects of a random-
ized controlled trial comparing aerobic exercise training to
usual care in postmenopausal breast cancer survivors. Breast
cancer survivors tend to be sedentary and overweight and
susceptible to development of metabolic syndrome; however,
9–14.9 metabolic equivalent task (MET) hours per week
of physical activity (equivalent to walking at an average
pace approximately 3–5 hours per week) is associated with
50% reduction in the risk of mortality compared to those
with lower physical activity levels (i.e., <3 MET hours per
week) [16]. Metabolic syndrome may not only increase risk
of cardiovascular disease in this population but is also
associated with increased risk of breast cancer recurrence.
Overall the 6-month aerobic training intervention resulted in
a significant reduction in fasting glucose levels. In addition,
those compliant with the exercise intervention (defined as 120
minutes per week of aerobic exercise) reducedmetabolic syn-
drome (as a sum of 𝑧-scores calculated from each metabolic
syndrome risk factor) compared to those who were not
compliant with the exercise program. This study has two
important implications: (1) only aminimal amount of aerobic
exercise can reduce metabolic syndrome risk in breast cancer
survivors (i.e., less than 20 minutes per day); and (2) it is
important to focus on strategies that can increase adherence
to exercise programs in this population to derive best results.
M. Y. Solis et al. assessed the effects of exercise training
in a normal-weight group of women who had undergone
abdominal liposuction surgery. There were some negative
effects on adiponectin and cytokine levels six months after
the surgery, including increased TNF-alpha and IL-6 mRNA
levels in subcutaneous adipose tissue biopsies and decreased
adipose tissue mRNA and serum levels of adiponectin.
Exercise improved insulin sensitivity but had no effect on
correcting the deleterious effect of the surgery on adiponectin
and cytokines. Overall the negative effect of the surgery on
adiponectin and cytokines was not associated with insulin
resistance. Future studies will have to determine whether a
longer follow-up after liposuction surgery is associated with
development of metabolic dysregulation associated with the
negative effects on adipokines and cytokines.
A challenge with many studies evaluating the effect of
exercise training or fitness levels on central adipose tissue is
separating the subcutaneous adipose tissue from the more
metabolically active visceral adipose tissue depots. S. Kim et
al. utilized computed tomography scans to provide a careful
quantitation of these adipose depots in a cross-section of
overweight and obese individuals. They demonstrated that
cardiovascular fitness (determined by recovery heart rate)
was inversely associated with visceral but not subcutaneous
adipose tissue. This association suggests that there may be
a link between fitness and adipose tissue deposition. In
addition, it intimates that improvement in cardiovascular
fitness may target the adipose tissue depot that is most
associated with development of dysfunction of adipokines
and cytokines and metabolic syndrome.
Adipokine and cytokine dysfunction is one of the leading
mechanisms linking obesity with insulin resistance, type
2 diabetes, cardiovascular disease, and cancer. Moreover,
visceral adipose tissue is associated with a distinct adipokine
and cytokine profile that is more detrimental than subcu-
taneous adipose tissue. For example, visceral adipose tis-
sue secretes high levels of plasminogen activator inhibitor
1, an anti-fibrinolytic protein with prothrombotic effects,
and accumulation of visceral adipose tissue is associated
with hyposecretion of adiponectin [17]. Liposuction removes
mainly subcutaneous adipose tissue, leaving visceral adipose
tissue intact; this could explain the minimal beneficial effect
of liposuction on insulin resistance [18]. M. Y. Solis et al.
reported a detrimental impact of abdominal liposuction
on adiponectin and cytokines. Weight reduction through
exercise and proper diet, therefore, still remains as the best
way to reduce adiposity and improve metabolic profiles. The
study by S. Kim et al. draws some attention to this point
in that CT-measured visceral adipose tissue mass and not
subcutaneous adipose tissue mass was inversely associated
with cardiopulmonary fitness. The group of manuscripts in
this issue highlights the importance of exercise for attenu-
ating adipokine and cytokine dysfunction and ameliorating
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